Publications

Publications

Filter Results: (481) Arrow Down
Filter Results: (481) Arrow Down Arrow Up

Show Results For

Show Results For

← Page 9 of 481 Results →

    David A. Thomas

    David Thomas is H. Naylor Fitzhugh Professor of Business Administration at Harvard Business School.  His research addresses issues related to executive development, cultural diversity in organizations, leadership and organizational change.  He recently served as a... View Details

    Keywords: biotechnology; biotechnology; biotechnology; biotechnology; biotechnology; biotechnology
    • Web

    Blavatnik Fellowship in Life Science Entrepreneurship - Health Care

    closely with leading biotech industry and biomedical authorities, receive programmatic guidance and mentorship, and join a community of entrepreneurs shaping the future of science. “ Bringing life science innovations to the global... View Details
    • September 2008 (Revised July 2012)
    • Case

    Khosla Ventures: Biofuels Strategy

    By: Joseph B. Lassiter III, William A. Sahlman and Alison Berkley Wagonfeld
    By 2008, a number of the firm's early cleantech investments were showing promise, and the companies were starting to need significantly more money to create the massive scale required in the energy sector. As Khosla thought about the hundreds of millions of dollars... View Details
    Keywords: Entrepreneurial Marketing; Entrepreneurial Finance; New Product Development; Partnerships; Entrepreneurial Management; Venture Capital; Strategy; Partners and Partnerships; Renewable Energy; Entrepreneurship; Investment Funds; Environmental Sustainability; Product Development; Biotechnology Industry; Biotechnology Industry
    Related
    • 18 Jul 2024
    • Blog Post

    Harvard Business School Announces Its 2024-2025 Blavatnik Fellows

    alumni and Harvard-affiliated postdoctoral researchers the opportunity to advance new ventures around promising life science technologies and develop their leadership talents during a 12-month fellowship year. Fellows work closely with leading biotech View Details
    • 14 Sep 2010
    • First Look

    First Look: September 14, 2010

    involved in the production of clean energy. One of the key bottlenecks threatening innovation in energy production is the inability of VCs to exit their investments at the appropriate time. This hurdle did exist in industries such as... View Details
    Keywords: Sean Silverthorne

      Karim R. Lakhani

      Karim R. Lakhani is the Dorothy & Michael Hintze Professor of Business Administration at the Harvard Business School. He specializes in technology management, innovation, digital transformation and artificial... View Details

      Keywords: biotechnology; biotechnology; biotechnology; biotechnology; biotechnology; biotechnology; biotechnology; biotechnology; biotechnology; biotechnology

        Josh Lerner

        Josh Lerner is the Jacob H. Schiff Professor at Harvard Business School and Co-Director of the HBS Private Capital Project.  Much of his research focuses on venture capital and private equity organizations.  (This research is summarized in his books The Money of... View Details

        Keywords: biotechnology; biotechnology; biotechnology
        • September 2003 (Revised March 2007)
        • Case

        Direvo Biotech AG

        Describes the financing and growth decisions facing Direvo, a young German biotech firm with a customer/partner that wants to become an investor. Also discusses the business model for Direvo's directed evolution technology, with applications in both industrial enzymes... View Details
        Keywords: Business Model; Decisions; Business Exit or Shutdown; Value; Business Startups; Biotechnology Industry; Germany
        Related

          Srikant M. Datar

          Srikant M. Datar became the eleventh dean of Harvard Business School on 1 January 2021. During his tenure as a faculty member, he served as Senior Associate Dean for University Affairs (including Faculty Chair of the Harvard Innovation Lab), for Research, for... View Details

          Keywords: accounting industry; accounting industry; accounting industry; accounting industry; accounting industry; accounting industry; accounting industry; accounting industry; accounting industry; accounting industry; accounting industry; accounting industry; accounting industry; accounting industry; accounting industry

            Andy Wu

            Andy Wu is the Arjun and Minoo Melwani Family Associate Professor of Business Administration in the Strategy Unit at Harvard Business School, where he teaches in the MBA and Executive Education programs. He researches, teaches, and advises managers... View Details

            Keywords: e-commerce industry; e-commerce industry; e-commerce industry; e-commerce industry; e-commerce industry
            • November 2017
            • Case

            Passion and Strategy: Novozymes' Embrace of the UN Sustainable Development Goals

            By: Andy Zelleke and Emilie Billaud
            This case explores the sustainability efforts at Novozymes, the world's largest and oldest producer of industrial enzymes. In 2015, the Danish company became the world’s first company known to have crafted a new corporate strategy based on the United Nations... View Details
            Keywords: Corporate Governance; Transformation; Environmental Sustainability; Corporate Social Responsibility and Impact; Mission and Purpose; Business and Shareholder Relations; Business and Stakeholder Relations; Business Strategy; Organizational Culture; Organizational Change and Adaptation; Biotechnology Industry; Europe; Denmark
            Related

              Ranjay Gulati

              Ranjay Gulati is the Paul R. Lawrence MBA Class of 1942 Professor of Business Administration and the former Unit Head of the Organizational Behavior Unit at Harvard Business School. His pathbreaking research, which focuses on unlocking organizational and unleashing... View Details

              Keywords: biotechnology; biotechnology; biotechnology; biotechnology; biotechnology; biotechnology; biotechnology; biotechnology
              • January 2014 (Revised December 2014)
              • Case

              GenapSys: Business Models for the Genome

              By: Richard G. Hamermesh, Joseph B. Fuller and Matthew Preble

              GenapSys, a California-based startup, was soon to release a new DNA sequencer that the company's founder, Hesaam Esfandyarpour, believed was truly revolutionary. The sequencer would be substantially less expensive—potentially costing just a few thousand dollars—and... View Details

              Keywords: DNA Sequencing; Life Sciences; Business Model; Innovation ＆ Entrepreneurship; Health Care and Treatment; Genetics; Business Strategy; Biotechnology Industry; Biotechnology Industry; Biotechnology Industry; Biotechnology Industry; Biotechnology Industry; United States
              Related

                Forest L. Reinhardt

                Forest L. Reinhardt is the John D. Black Professor of Business Administration at Harvard Business School, and HBS’s Senior Associate Dean for Faculty Promotions and Tenure.

                Professor Reinhardt is interested in the relationships between market and nonmarket... View Details

                Keywords: biotechnology; biotechnology; biotechnology; biotechnology; biotechnology; biotechnology; biotechnology; biotechnology; biotechnology; biotechnology; biotechnology; biotechnology; biotechnology; biotechnology; biotechnology; biotechnology

                  Nitin Nohria

                  Nitin Nohria served as the tenth dean of Harvard Business School from 2010-2020. He previously served as co-chair of the Leadership Initiative, Senior Associate Dean of Faculty Development, and Head of the Organizational Behavior unit.

                  As Dean, building on... View Details

                  Keywords: accounting industry; accounting industry; accounting industry; accounting industry; accounting industry; accounting industry; accounting industry; accounting industry; accounting industry; accounting industry; accounting industry; accounting industry; accounting industry; accounting industry; accounting industry; accounting industry; accounting industry; accounting industry; accounting industry; accounting industry; accounting industry

                    Maria P. Roche

                    Maria Roche is an Assistant Professor in the Strategy Unit. She teaches the MBA elective Innovating at Scale and contributes to teaching in executive education programs. Her research examines how specialized knowledge is commercialized and how... View Details

                    Keywords: education industry; education industry; education industry
                    • Web

                    Sample Student Projects - Institute For Strategy And Competitiveness

                    Cluster (2013) Germany Baden-Wuerttemberg Automobile Cluster (2015) Germany Wind Power Cluster (2010) Germany’s Photovoltaic Cluster (2009) Hamburg Aviation Cluster (2009) Biotechnology and Life Sciences in Munich (2007) Ghana Ghana Cocoa... View Details

                      Malcolm P. Baker

                      Malcolm Baker is the Robert G. Kirby Professor of Business Administration at the Harvard Business School, where he teaches the required course in finance and a short immersive program on investing in life sciences.

                      His research is in the... View Details

                      Keywords: biotechnology; biotechnology; biotechnology; biotechnology; biotechnology; biotechnology; biotechnology; biotechnology; biotechnology
                      • 09 Apr 2012
                      • Research & Ideas

                      Who Sways the USDA on GMO Approvals?

                      Traditional Theories Break Down As Hiatt began investigating, he found that traditional theories of capture such as lobbying and campaign contributions had little effect on whether any particular GMO was approved. Even more direct means of influence such as scientific... View Details
                      Keywords: by Michael Blanding; Biotechnology; Biotechnology; Biotechnology
                      • 30 May 2007
                      • Research & Ideas

                      Health Care Under a Research Microscope

                      The $2 trillion health care system is one of the United States' largest industries—but one of its worst performing by almost any measure other than technological innovation. The problems are painful, including escalating costs, expensive insurance premiums, lack of... View Details
                      Keywords: by Sean Silverthorne; Biotechnology; Biotechnology